An Rx for Watson Pharmaceuticals (at Barron's Online)

Bristol-Myers shares dip on failed drug study (AP)
Shares of Bristol-Myers Squibb Co. dipped Wednesday after the drug developer said its developing blood thinner apixaban failed in a late-stage study.

Cell Genesys at all-time low after GVAX trial ends (AP)
Shares of Cell Genesys Inc. crashed to an all-time low Wednesday after the company stopped a clinical trial of its prostate cancer vaccine GVAX because of patient deaths.

Medical Stock Picks from Alabama U. (at CNBC)

Time to Head Back to School (CNBC)
<summary><![CDATA[Market insights from some of the leading student run investment funds around the country, with Laura Bordelon University of Alabama at Birmingham Green and Gold Fund portfolio manager]]></summary><image>http://us.news2.yimg.co m/us.yimg.com/p/fi/18/01/36.jpg</image><guid>/yfinanc e/cnbc2/Government/833790354</guid><link><![CDATA[ javascript:void(window.open('http://cosmos.bcst.yahoo.com/up /finance?ch=4043681&cl=9471651&lang=','playerWi ndow','width=793,height=666,scrollbars=no'));]]> ;</link><plink>http://www.cnbc.com/</plink>< plogo>http://l.yimg.com/us.yimg.com/i/us/fi/gr/partner_logos/c nbc_1.png</plogo>